1. Home
  2. TKLF vs ASBP Comparison

TKLF vs ASBP Comparison

Compare TKLF & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

N/A

Current Price

$3.04

Market Cap

15.6M

ML Signal

N/A

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$0.13

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKLF
ASBP
Founded
2006
2021
Country
Japan
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
15.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
TKLF
ASBP
Price
$3.04
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.3K
17.6M
Earning Date
12-19-2025
11-14-2025
Dividend Yield
7.88%
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
$302,537,158.00
$1,941.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.92
N/A
Revenue Growth
37.82
N/A
52 Week Low
$2.10
$0.07
52 Week High
$4.32
$15.80

Technical Indicators

Market Signals
Indicator
TKLF
ASBP
Relative Strength Index (RSI) 61.66 54.29
Support Level $2.74 $0.09
Resistance Level $3.14 $0.14
Average True Range (ATR) 0.21 0.01
MACD 0.09 0.01
Stochastic Oscillator 91.13 84.40

Price Performance

Historical Comparison
TKLF
ASBP

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: